APA (7th ed.) Citation

IA, A., MF, E., RM, A., & MAA, F. (2022). The anti-COVID-19 drug Favipiravir: Degradation, Method development, Validation, NMR/LC-MS characterization, and In-vitro safety evaluation. Chemicke zvesti, 76(10), 6415. https://doi.org/10.1007/s11696-022-02327-5

Chicago Style (17th ed.) Citation

IA, Abdallah, El-Behairy MF, Ahmed RM, and Fayed MAA. "The Anti-COVID-19 Drug Favipiravir: Degradation, Method Development, Validation, NMR/LC-MS Characterization, and In-vitro Safety Evaluation." Chemicke Zvesti 76, no. 10 (2022): 6415. https://doi.org/10.1007/s11696-022-02327-5.

MLA (9th ed.) Citation

IA, Abdallah, et al. "The Anti-COVID-19 Drug Favipiravir: Degradation, Method Development, Validation, NMR/LC-MS Characterization, and In-vitro Safety Evaluation." Chemicke Zvesti, vol. 76, no. 10, 2022, p. 6415, https://doi.org/10.1007/s11696-022-02327-5.